Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Exact Sciences announces pricing of underwritten public offering of common stock

Exact Sciences Corp. today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public.

4 Apr 2014

Adenoma detection rates track future risk of colorectal cancer, study finds

A study of over 224,000 patients and more than 314,000 colonoscopies found that adenoma detection rates closely tracked the future risk of colorectal cancer. The study was published in The New England Journal of Medicine.

2 Apr 2014

Researchers discover involvement of common gut bacterium in bowel cancer

New evidence that a common gut bacterium is involved in bowel cancer has been discovered by researchers from the Department of Physiology and Medical Physics in RCSI (Royal College of Surgeons in Ireland). The research is published in this month’s edition of the European Journal of Clinical Microbiology & Infectious Diseases.

2 Apr 2014

Study: Obesity causes changes in colon that may lead to colorectal cancer

Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United States.

2 Apr 2014

L.A. Times: More than 9 million uninsured gain coverage

The newspaper's tally draws on state and federal enrollment reports, surveys by consultants and interviews with insurance and government officials. Meanwhile, insurers and others intensify efforts to sign up young customers.

1 Apr 2014

First Edition: March 31, 2014

Today's early morning highlights from the major news organizations offer assessments of the administration's campaign to get people signed up for health care and a look at the issues going forward after today's deadline for most enrollments.

31 Mar 2014

IRB researchers identify dual role of p38 protein in colon cancer

A team headed by Angel R. Nebreda at the Institute for Research in Biomedicine identifies a dual role of the p38 protein in colon cancer. The study demonstrates that, on the one hand, p38 is important for the optimal maintenance of the epithelial barrier that protects the intestine against toxic agents, thus contributing to decreased tumour development.

28 Mar 2014

Johns Hopkins researchers use 3-D MRI scans to accurately measure tumor viability and death

In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy - delivered directly through a tumor's blood supply - is working.

27 Mar 2014

Beer marinade help reduce formation of harmful substances in grilled meats

The smells of summer - the sweet fragrance of newly opened flowers, the scent of freshly cut grass and the aroma of meats cooking on the backyard grill - will soon be upon us.

27 Mar 2014

EndoChoice launches website to provide patients with latest information on colorectal cancer screening

EndoChoice Inc. maker of the Fuse Full Spectrum Endoscopy system that allows doctors to see more of the GI tract than ever before today announced the launch of FuseColonoscopy.org to provide patients with the latest information on colorectal cancer screening.

26 Mar 2014

Radiation therapy fights cancer in more ways than one

Radiation therapy fights cancer in more ways than one. Not only does it force cancer cells to self-destruct, but several studies demonstrate that it also activates the immune system to attack tumor cells.

25 Mar 2014

Taiho Pharmaceutical obtains approval in Japan for anticancer drug Lonsurf

Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).

24 Mar 2014

Endomagnetics receives award for Best New Product

Endomagnetics, the company enjoying international commercial success with its medical device technology, has been given the award for Best New Product or Business Model in this year’s Business Weekly awards. The award was made at a gala dinner at Queens’ College, Cambridge last night.

20 Mar 2014

Detection of genetic abnormalities could improve effectiveness of colon cancer screening

A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member.

20 Mar 2014

Novel feedback provides mechanistic link between chronic inflammation and carcinogenesis

Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have discovered a novel feedback mechanism that provides a mechanistic link between chronic inflammation and carcinogenesis.

20 Mar 2014

New stool-based screening test detects 92% of colorectal cancer

A new, non-invasive, stool-based screening test detected 92% of colorectal cancer (CRC), according to a multicenter trial published online today in the New England Journal of Medicine.

20 Mar 2014

Incidence of colon cancer in the US is decreasing with increased use of colonoscopy

Colorectal cancer, commonly called colon cancer, is the third most common cancer and the third leading cause of cancer death in the United States. Research, published today, by the American Cancer Society shows that the incidence of colorectal cancer among adults aged 50 years or more has fallen by 30% in the US over the last 10 years. This is thought to be primarily due to the widespread uptake of colonoscopy screening, which has almost tripled among adults aged 50 to 75 years (19% in 2000; 55% in 2010).

17 Mar 2014

Incidence of colon cancer have dropped sharply in older adults

Colon cancer incidence rates have dropped 30 percent in the U.S. in the last 10 years among adults 50 and older due to the widespread uptake of colonoscopy, with the largest decrease in people over age 65.

17 Mar 2014

iCAD prices underwritten public offering of 2,400,000 shares of common stock

iCAD, Inc. ("iCAD"), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.

12 Mar 2014

Researchers seek 400 treatment-naïve colon participants to measure non-invasive blood test

Investigators with Baylor Research Institute, a research arm of Baylor Scott & White Health, have opened participation for a new clinical trial that could determine whether a certain blood test can detect colon cancer before it even develops.

12 Mar 2014